Save
Inhibitors in hemophilia: Risk factors, biomarkers and other predictors
ISTH Academy, Samantha Gouw and Rolf Carl Ljung, 261656
Inhibitors in hemophilia: Risk factors, biomarkers and other predictors
ISTH Academy, Samantha Gouw and Rolf Carl Ljung, 273713
How We Treat Female Teens : patients with bleeding disorders & patients on anticoagulant therapies
ISTH Academy, Loren D’Angelo and Marilyn Blumenstein, 261693
Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon
ISTH Academy, Els Bailleul, 278059
Disseminated intravascular coagulation in cardiac arrest and resuscitation
ISTH Academy, Mattia Piredda, 278060
Emicizumab and thrombosis: The story so far
ISTH Academy, Michael Makris, 278061
Endogenous sex hormones and risk of venous thromboembolism in young women
ISTH Academy, Suzanne Cannegieter, 278062
Monitoring of blood coagulation with non‐contact drop oscillation rheometry
ISTH Academy, Correspondence |R. Glynn Holt, 278063
Thromboprophylaxis in pregnant women: For whom and which LMWH dosage? Reply
ISTH Academy, Claire McLintock, 278064
Curated disease‐causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH
ISTH Academy, Correspondence |Kathleen Freson, 278065
What the Neighbours Say
ISTH Academy, Session Speakers, 278066
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Comment
ISTH Academy, Wolfgang Miesbach, 278067
Assessment of the analytical performances and sample stability on ST Genesia system using the STG‐DrugScreen application
ISTH Academy, Jonathan Douxfils, 278068
Endothelial force awakens a mechanism of portal hypertension: It's a neutrophil extracellular trap!
ISTH Academy, James Luyendyk, 278069
Could the YEARS algorithm be used to exclude pulmonary embolism during pregnancy? Data from the CT‐PE‐pregnancy study
ISTH Academy, Farrukh Awan, 278070
Thromboprophylaxis in pregnant women: For whom and which LMWH dosage?
ISTH Academy, Bernard Tardy, 278071
Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism
ISTH Academy, Birgit Sm�brekke, 278072
Risk of thromboembolic and bleeding outcomes following hematological cancers: A Danish population‐based cohort study
ISTH Academy, Anne Kristine Engebretsen, 278073
Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH
ISTH Academy, Correspondence |Simon Noble, 278074
Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues
ISTH Academy, Correspondence |Siamak Sabour, 278075
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Reply
ISTH Academy, Flora Peyvandi, 278076
Prophylactic administration of glycoPEGylated factor IX provides protection and joint outcome superior to recombinant factor IX after induced joint bleeding
ISTH Academy, Carsten Ley, 278077
Association of complete blood count parameters, d‐dimer, and soluble P‐selectin with risk of arterial thromboembolism in patients with cancer
ISTH Academy, Cihan Ay, 278078
Issue Information
ISTH Academy, Session Speakers, 278079
ISTH News and Updates: Join the ISTH Today
ISTH Academy, Session Speakers, 278080
Toward standardization of assays measuring extracellular vesicle‐associated tissue factor activity
ISTH Academy, Johannes Thaler, 278081
Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues
ISTH Academy, Abdoellakhan Rahat, 278082
Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates
ISTH Academy, Francesco Bernardi, 278083
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta‐analysis
ISTH Academy, Cecilia Becattini, 278084
Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding
ISTH Academy, Mettine Bos, 278085
The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen
ISTH Academy, Mark Walters & Abdalla Fayyad, 278086
Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation
ISTH Academy, Toshiaki Iba, 278087
von Willebrand factor in experimental malaria‐associated acute respiratory distress syndrome
ISTH Academy, Simon F. De Meyer, 278088
Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran
ISTH Academy, Stephan Glund, 278089
Diagnostic and Score Value of Ultrasound and Magnetic Resonance Imaging in Hemophilia Arthropathy
ISTH Academy, Fei Ma, 273745
Olfactory Receptors and Dysregulated Platelet Activity in Abdominal Aortic Aneurysms
ISTH Academy, Scott Cameron, 273752
The Thrombocytopathy in the Netherlands Study: A Horizontal Diagnostic Approach for Suspected Congenital Platelet Defects
ISTH Academy, Rolf Urbanus, 273754
Joint Bleeds in Paediatric Patients with Haemophilia A: A CHESS Study Analysis
ISTH Academy, Jamie O’Hara, 273785
Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of ACT017, an Anti-platelet Glycoprotein VI Fab: First in Human Healthy Volunteer Trial
ISTH Academy, Martine Jandrot-Perrus, 273796
Novel Murine Venous Thromboembolism Model to Evaluate Role of Factor XIII in Pulmonary Embolism Risk
ISTH Academy, Sravya Kattula, 273797
Characterization of Factor VIII Binding Sites on the Low-density Lipoprotein Receptor-related Protein 1 (LRP) Suggests a Dynamic Bivalent Mode of this Interaction
ISTH Academy, Andrey Sarafanov, 273815
Identification and Functional Characterization of a New Thrombus-resolving Regulatory T-cell Population
ISTH Academy, Fatemeh Shahneh, 273833
Confirmation of ACTN1 Variants as the Cause of Macrothrombocytopenia Using an in Vitrocellular Model
ISTH Academy, Yuki Takagi, 273840
Variants from Patients with Hemophilia Impair Proper Carboxylation of Factor IX
ISTH Academy, Nicholas Popp, 273845
Neutrophils Prothrombotic Characteristics during Myeloproliferative Neoplasms
ISTH Academy, Chloé James, 273861
Association of Body Weight with Efficacy and Safety of Apixaban and Rivaroxaban in Relation to Low Molecular Heparin and Vitamin K Antagonists in Acute Venous Thromboembolism
ISTH Academy, Waldemar Wysokinski, 273862
Isolation of Silica-free DNA and Studies of its Effects on Organ Damage in Mice
ISTH Academy, Sarah Medeiros, 273867
The Fibrin αC Region is Critical for Mechanical Strength, Resistance to Fibrinolysis and the Formation of a Stable Whole Blood Clot
ISTH Academy, Helen McPherson, 273873
Targeting Protease Nexin-1, a Natural Anticoagulant, to Control Bleeding in Hemophilia A
ISTH Academy, Karen Aymonnier, 273874
Efficacy and Safety of BAY 94-9027 is Sustained for 5 Years: Outcomes in 36 Patients in the PROTECT VIII Extension Study
ISTH Academy, Mark Reding, 273894
Ceramide 1 Phosphate Is a Potent Chemoattractant Factor of Endothelial Colony Forming Cells and Improve Post Ischemia Tissue Regeneration
ISTH Academy, Hebe Agustina Mena, 273904
Endothelial Plasminogen Activator Inhibitor-1 Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of Activated Factor XI
ISTH Academy, Cristina Puy, 273906
Coagulation Activation Induced by Platelet-Derived Microvesicles is Mediated by Kallikrein-Dependent Activation of Factor IX
ISTH Academy, Nigel Key, 273908
Thrombus Resolution in Splanchnic Vein Thrombosis
ISTH Academy, Ana Casanegra, 273917
Two Birds, One Stone: Anti-β3 Integrin PSI Domain Antibodies Inhibit Both Platelet Aggregation and Blood Coagulation
ISTH Academy, Miguel Neves, 273921
Factor VIII (FVIII)-Haplotype Mismatch Increases Risk of Inhibitor Development in the Treatment of Hemophilia A (HA)
ISTH Academy, Tom Howard, 273928
Use of Direct Oral Anticoagulants in Patients with Different Types of Hereditary Thrombophilia: A Retrospective Cohort Study
ISTH Academy, Elena Campello, 273932
Unexpected Enhancement of FVIII Immunogenicity by Endothelial Expression in Lentivirus-transduced and Transgenic Mice
ISTH Academy, Qizhen Shi, 273938
Extended Stability of Activated TAFI Normalizes Vascular Dysfunction in Hemophilic Joint Disease in Mice
ISTH Academy, Tine Wyseure, 273940
Spontaneous Bleeding and Poor Bleeding Response with Extended Half-life Factor IX Products: A Survey of Select US Hemophilia Treatment Centers
ISTH Academy, Robert Sidonio, 273953
DOAC Plasma Concentrations in High Weight Patients: An Observational Study
ISTH Academy, Anne Celine Martin, 273958
Targeting Activated Platelets in the Tumor Microenvironment for Localized Delivery of Antibody-drug Conjugates to Tumors and Metastases
ISTH Academy, James McFadyen, 273990
Australian and New Zealand Registry of Anticoagulation in the Obese
ISTH Academy, Georgia McCaughan, 274005
First Generation PI3KC2α Inhibitors are Potently Anti-Thrombotic and Improve on the Safety Profile of Current Anti-Platelet Therapies
ISTH Academy, Mitchell Moon, 274013
Transforming Growth Factor β Released by Platelets Primes Macrophage Activation and Extracellular Trap Formation, Thereby Influencing Breast Cancer Growth in Mice
ISTH Academy, Elmina Mammadova-Bach, 274035
Inhibition of Platelet GPVI Induces Intratumor Hemorrhage and Increases Efficacy of Chemotherapy in Mice
ISTH Academy, Julia Volz, 274053
New Constitutional GATA1 Variants Study Reveals the Contribution of GATA1 in MYH10 Silencing During Megakaryopoiesis
ISTH Academy, Paul Saultier, 274054
High-molecular-Weight Kininogen Is a Critical Component of Host Defense against Gram-negative Bacteria: Evidence from a Humanized HK Mouse Model
ISTH Academy, Aizhen Yang, 274059
Factor XII-W268R, a Human Mutation Causing Autoinflammation, Accelerates Activation through Exposure of the Activation Loop
ISTH Academy, Chantal Clark, 274060
Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Human Fibrinogen Disorders
ISTH Academy, Cristina Freire Sanz, 274062
Recombinant Factor VIII Fc Fusion Protein Inhibits Inflammatory Osteoclast Formation in vitro
ISTH Academy, Robert Peters, 274074
Detection and Analysis of Gene Mutations in Patients with Fibrinogen Deficiency by Next Generation Sequencing
ISTH Academy, Boyang Sun, 274085
A RNA Interference-based Approach to Autosomal Dominant Glanzmann Thrombasthenia: A Step towards Personalized Treatment
ISTH Academy, Loredana Bury, 274096
Characterization of Blood Outgrowth Endothelial Cells (BOECs) from Hermansky-Pudlak Syndrome (HPS) Type 1
ISTH Academy, Giulio Purgatorio, 274099
Impaired Hemostatic Activity of Healthy Transfused Platelets in Select Inherited Platelet Disorders: Mechanisms and Implications
ISTH Academy, Robert Lee, 274106
Blood Endothelial Progenitor Cell-on-a-Chip: A Disease and Patient-specific Cell Source for in vitro Vascular Tissue Engineered Platforms
ISTH Academy, Tanmay Mathur, 274111
Novel NADPH Oxidase 1-selective Inhibitors Impair Collagen-dependent Platelet Activation and Thrombus Formation in vitro and Ferric Chloride-induced Carotid Occlusion in vivo with Negligible Effects on Thrombin Responses and Bleeding Time
ISTH Academy, Giordano Pula, 274116
Understanding the Chromatin Regulatory Landscape Controlling Fibrinogen Gene Expression
ISTH Academy, Richard Fish, 274117
Hemarthrosis in FVIII-deficient Mice Causes Altered Expression of Local and Systemic Iron Regulators and Defective Iron Clearance from the Joint
ISTH Academy, Annette von Drygalski, 274128
Targeting Protein S Protects Mice with Hemophilia A from Acute and Chronic Hemartrosis
ISTH Academy, Raja Prince, 274131
Suppression of FVIII-specific Memory B Cells by Regulatory T Cells Expressing BARs
ISTH Academy, Ai-Hong Zhang, 274138
Intracranial Hemorrhage in Hemophilia - A Systematic Review
ISTH Academy, AnneFleur Zwagemaker, 274141
The Fibrin αC Region is Critical for Mechanical Strength, Resistance to Fibrinolysis and the Formation of a Stable Whole Blood Clot
ISTH Academy, Helen McPherson, 275139
First Generation PI3KC2α Inhibitors are Potently Anti-Thrombotic and Improve on the Safety Profile of Current Anti-Platelet Therapies
ISTH Academy, Mitchell Moon, 275142
Two Birds, One Stone: Anti-β3 Integrin PSI Domain Antibodies Inhibit Both Platelet Aggregation and Blood Coagulation
ISTH Academy, Miguel Neves, 275143
Anticoagulant-Associated Bleeding in AF Patients
ISTH Academy, Elaine Hylek, 275214
Triple Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI/Stenting
ISTH Academy, Gregory Lip, 275215
Structure and Function of FXI/FXII
ISTH Academy, Jonas Emsley, 275217
Clinical Trials with FXI Inhibitors
ISTH Academy, Jeffrey Weitz, 275218
Mechanisms of Fc-Independent Thrombocytopenia
ISTH Academy, Heyu Ni, 275219
Thrombopoietin Receptor Agonists
ISTH Academy, David Kuter, 275220
Thrombocytopenia in Pregnancy
ISTH Academy, Terry Gernsheimer, 275221
Epigenetics in Hemostasis
ISTH Academy, Elisa Danese, 275223
Platelet Proteome
ISTH Academy, Jonas Enrique Perales Aguilar, 275224
Cryopreserved Platelets in Trauma
ISTH Academy, Michael Reade, 275225
Tranexamic Acid: An Effective Treatment for Acute Severe Bleeding
ISTH Academy, Ian Roberts, 275226
Molecular Links Between Coagulation and Innate Immunity
ISTH Academy, Edward Conway, 275228
Endothelial Cell Contribution to the Pathology in HIT
ISTH Academy, Lubica Rauova, 275229
Management Strategies for Hematological Derangement in Dengue Hemophilia Fever
ISTH Academy, Ampaiwan Chuansumrit, 275231
Hemostasis in Liver Disease
ISTH Academy, Maria Magnusson, 275232

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings